Impact of N-PEP-12 Supplementation on Attentional Performance and Mental Wellbeing in Healthy Adults with Subjective Cognitive Complaints: A Randomized, Placebo-Controlled Trial
Nutrients · 2026
DOI: 10.3390/nu18162739 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2026. Verfasst von Diana Chira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Victor Babeș 43, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Dietary Supplements, Attention, Cognition, Mental Health. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for the Study of Nanoneurosciences and Neuroregeneration (FSNANO).
Abstract (Originalsprache)
Background
Subjective cognitive complaints (SCCs) are common in middle-aged and older adults and may reflect early cognitive changes, alongside alterations in stress, mood, sleep, and quality of life. N-PEP-12 is a peptide-based nutritional supplement with potential neuroprotective effects, but evidence of its benefits in healthy adults with SCCs remains limited.
Objective
To evaluate the effects of N-PEP-12 supplementation on attention, cognitive function, and mental wellbeing in healthy middle-aged and older adults with SCCs.
Methods
In this prospective, randomized, double-blind, placebo-controlled trial, 276 participants aged 50–75 years with SCCs and no clinically significant cognitive impairment were randomized to placebo, N-PEP-12 45 mg, or N-PEP-12 90 mg. Assessments were performed at baseline and after 30, 90, and 180 days. Primary outcomes included Test of Attentional Performance measures. Secondary outcomes included WAIS-IV Digit Span Forward and Backward, perceived stress, mood, sleep quality, and EQ-5D-5L visual analog scale.
Results
Across the three primary attention outcomes analyzed jointly in a multivariate repeated-measures model, there was a significant group-by-visit interaction (p = 0.003) and a significant effect of visit (p < 0.001), without a significant main effect of treatment arm (p = 0.133), indicating a time-dependent treatment effect. This result was obtained in a sensitivity analysis population in which missing values were imputed under assumptions least favorable to the active arms. In exploratory endpoint-specific comparisons at 90 days, both N-PEP-12 groups showed greater improvements than placebo in alertness, attention omissions and memory omissions, and Digit Span Forward and Backward scores also improved. In a subsequent uncontrolled extension phase, in which all participants received active treatment, participants initially assigned to placebo showed comparable improvements after switching to N-PEP-12 90 mg. These observations are exploratory. Adverse events were infrequent and similarly distributed across groups.
Conclusions
N-PEP-12 supplementation was associated with improvements in attention, working memory, and mental wellbeing in healthy middle-aged and older adults with subjective cognitive complaints. These findings support further investigation of N-PEP-12 as a nutritional intervention for early subjective cognitive changes associated with aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosciences, Iuliu Hațieganu University of Medicine and Pharmacy, Victor Babeș 43, 400012 Cluj-Napoca, Romania.
- RoNeuro Institute for Neurological Research and Diagnostic, Mircea Eliade 37, 400354 Cluj-Napoca, Romania.
- Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hațieganu University of Medicine and Pharmacy, Gheorghe Marinescu 38, 400337 Cluj-Napoca, Romania.
- Department of Translational Neurosciences, MEDFUTURE, Iuliu Hațieganu University of Medicine and Pharmacy, Gheorghe Marinescu 38, 400337 Cluj-Napoca, Romania.
- Department of Complementary Sciences, Discipline of Hygiene and Medical Ecology, Carol Davila University of Medicine and Pharmacy, 8 Eroii Sanitari Boulevard, 050474 Bucharest, Romania.
ORCID-Profile: Diana Chira, Nicoleta Jemna, Olivia Verișezan-Roșu, Ștefan Strilciuc, Vlad-Florin Chelaru
Förderung
- Foundation for the Study of Nanoneurosciences and Neuroregeneration (FSNANO)
Zitieren
APA
Chira, D., Jemna, N., Verișezan-Roșu, O., Buruiană, A. M., Strilciuc, Ș., Chelaru, V. F., Pârvu, S., & Mureșanu, D. F. (2026). Impact of N-PEP-12 Supplementation on Attentional Performance and Mental Wellbeing in Healthy Adults with Subjective Cognitive Complaints: A Randomized, Placebo-Controlled Trial. Nutrients. https://doi.org/10.3390/nu18162739
Vancouver
Chira D, Jemna N, Verișezan-Roșu O, Buruiană AM, Strilciuc Ș, Chelaru VF, et al. Impact of N-PEP-12 Supplementation on Attentional Performance and Mental Wellbeing in Healthy Adults with Subjective Cognitive Complaints: A Randomized, Placebo-Controlled Trial. Nutrients. 2026. doi:10.3390/nu18162739
BibTeX
@article{Chira2026,
author = {Chira, Diana and Jemna, Nicoleta and Verișezan-Roșu, Olivia and Buruiană, Ana-Maria and Strilciuc, Ștefan and Chelaru, Vlad-Florin and Pârvu, Simona and Mureșanu, Dafin Fior},
title = {Impact of N-PEP-12 Supplementation on Attentional Performance and Mental Wellbeing in Healthy Adults with Subjective Cognitive Complaints: A Randomized, Placebo-Controlled Trial},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18162739}
}
EUVIMED